1.
Similar herpes zoster incidence across Europe: results from a systematic literature review
Sybil
Pinchinat,
Ana
M
Cebrián-Cuenca,
Hélène
Bricout,
Robert
W
Johnson
BMC Infectious Diseases 2013, 13 :170 (10 April 2013)
Abstract | Full text | PDF | PubMed
2.
Prevalence of high-risk HPV types and associated genital diseases in women born in 1988/89 or 1983/84 – results of WOLVES, a population-based epidemiological study in Wolfsburg, Germany
Karl Ulrich
Petry,
Alexander
Luyten,
Annika
Justus,
Angelika
Iftner,
Sarah
Strehlke,
Axel
Reinecke-Lüthge,
Elisabeth
Grunwald,
Renate
Schulze-Rath,
Thomas
Iftner
BMC Infectious Diseases 2013, 13 :135 (13 March 2013)
Abstract | Full text | PDF | PubMed
3.
Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe
Rémi
Marty,
Stéphane
Roze,
Xavier
Bresse,
Nathalie
Largeron,
Jayne
Smith-Palmer
BMC Cancer 2013, 13 :10 (8 January 2013)
Abstract | Full text | PDF | PubMed
4.
Prevalence of low-risk HPV types and genital warts in women born 1988/89 or 1983/84 -results of WOLVES, a population-based epidemiological study in Wolfsburg, Germany
Karl Ulrich
Petry,
Alexander
Luyten,
Annika
Justus,
Angelika
Iftner,
Sarah
Strehlke,
Renate
Schulze-Rath,
Thomas
Iftner
BMC Infectious Diseases 2012, 12 :367 (21 December 2012)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
5.
Incidence and cost of anal, penile, vaginal and vulvar cancer in Denmark
Jens
Olsen,
Tine Rikke
Jørgensen,
Kristian
Kofoed,
Helle Kiellberg
Larsen
BMC Public Health 2012, 12 :1082 (17 December 2012)
Abstract | Full text | PDF | PubMed
6.
French women’s knowledge of and attitudes towards cervical cancer prevention and the acceptability of HPV vaccination among those with 14 – 18 year old daughters: a quantitative-qualitative study
Julie
Haesebaert,
Delphine
Lutringer-Magnin,
Julie
Kalecinski,
Giovanna
Barone,
Anne-Carole
Jacquard,
Véronique
Régnier,
Yann
Leocmach,
Philippe
Vanhems,
Franck
Chauvin,
Christine
Lasset
BMC Public Health 2012, 12 :1034 (27 November 2012)
Abstract | Full text | PDF | PubMed
7.
Evaluation of adult dTPaP vaccination coverage in France: experience in Lyon city, 2010–2011
Dominique
Baratin,
Corinne
Del Signore,
Jacques
Thierry,
Evelyne
Caulin,
Philippe
Vanhems
BMC Public Health 2012, 12 :940 (1 November 2012)
Abstract | Full text | PDF | PubMed
8.
Cost-effectiveness of vaccination with a quadrivalent HPV vaccine in Germany using a dynamic transmission model
Deniz
Schobert,
Vanessa
Remy,
Oliver
Schoeffski
Health Economics Review 2012, 2 :19 (25 September 2012)
Abstract | Full text | PDF | PubMed
9.
Predictors of human papillomavirus infection in women undergoing routine cervical cancer screening in Spain: the CLEOPATRE study
Esther
Roura,
Thomas
Iftner,
José
Vidart,
Susanne
Kjaer,
F
Bosch,
Nubia
Muñoz,
Santiago
Palacios,
Maria San
Rodriguez,
Carmen
Morillo,
Laurence
Serradell,
Laurence
Torcel-Pagnon,
Javier
Cortes,
Xavier
Castellsagué,
BMC Infectious Diseases 2012, 12 :145 (26 June 2012)
Abstract | Full text | PDF | PubMed
10.
Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: a review
Susanne
Hartwig,
Stina
Syrjänen,
Géraldine
Dominiak-Felden,
Maria
Brotons,
Xavier
Castellsagué
BMC Cancer 2012, 12 :30 (20 January 2012)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
11.
Epidemiology and cost of herpes zoster and postherpetic neuralgia among patients treated in primary care centres in the valencian community of Spain
Ana
M
Cebrián-Cuenca,
Javier
Díez-Domingo,
María
San-Martín-Rodríguez,
Joan
Puig-Barberá,
Jorge
Navarro-Pérez,
BMC Infectious Diseases 2011, 11 :302 (1 November 2011)
Abstract | Full text | PDF | PubMed
12.
Psychological impact, support and information needs for women with an abnormal Pap smear: comparative results of a questionnaire in three European countries
Joseph
Monsonego,
Javier
Cortes,
Daniel
da Silva,
Anna
Jorge,
Patrick
Klein
BMC Women's Health 2011, 11 :18 (25 May 2011)
Abstract | Full text | PDF | PubMed
13.
Innovative public-private partnerships to maximize the delivery of anti-malarial medicines: lessons learned from the ASAQ Winthrop experience
François
Bompart,
Jean-René
Kiechel,
Robert
Sebbag,
Bernard
Pecoul
Malaria Journal 2011, 10 :143 (23 May 2011)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
Editor’s summary
This case study describes how a public-private partnership initiated to develop a new anti-malarial combination, ASAQ Winthrop, has evolved over time to address issues posed by its deployment in the field.
14.
Economic burden of vulvar and vaginal intraepithelial neoplasia: retrospective cost study at a German dysplasia centre
Monika
Hampl,
Eduard
Huppertz,
Olaf
Schulz-Holstege,
Patrick
Kok,
Sarah
Schmitter
BMC Infectious Diseases 2011, 11 :73 (22 March 2011)
Abstract | Full text | PDF | PubMed
15.
Human papillomavirus genotype distribution in tonsil cancers
Jean
St Guily,
Christine
Clavel,
Claire
Okaïs,
Jean-Luc
Prétet,
Agnès
Beby-Defaux,
Gérard
Agius,
Philippe
Birembaut,
Anne-Carole
Jacquard,
Yann
Léocmach,
Benoît
Soubeyrand,
Didier
Riethmuller,
François
Denis,
Christiane
Mougin
Head & Neck Oncology 2011, 3 :6 (7 February 2011)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
16.
Incidence of anogenital warts in Germany: a population-based cohort study
Angela
A
Kraut,
Tania
Schink,
Renate
Schulze-Rath,
Rafael
T
Mikolajczyk,
Edeltraut
Garbe
BMC Infectious Diseases 2010, 10 :360 (23 December 2010)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
17.
Quality of life of homosexual males with genital warts: a qualitative study
Gitte
Lee Mortensen,
Helle
K
Larsen
BMC Research Notes 2010, 3 :280 (4 November 2010)
Abstract | Full text | PDF | PubMed
18.
Immunosenescence and Cytomegalovirus: where do we stand after a decade?
Graham
Pawelec,
Arne
Akbar,
Peter
Beverley,
Calogero
Caruso,
Evelyna
Derhovanessian,
Tamas
Fülöp,
Paul
Griffiths,
Beatrix
Grubeck-Loebenstein,
Klaus
Hamprecht,
Gerhard
Jahn,
Florian
Kern,
Sven
D
Koch,
Anis
Larbi,
Andrea
B
Maier,
Derek
Macallan,
Paul
Moss,
Sandrine
Samson,
Jan
Strindhall,
Emanuelle
Trannoy,
Mark
Wills
Immunity & Ageing 2010, 7 :13 (7 September 2010)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
19.
Head and neck cancers in France: an analysis of the hospital medical information system (PMSI) database
Jean
Lacau St Guily,
Isabelle
Borget,
Alexandre
Vainchtock,
Vanessa
Rémy,
Claire
Takizawa
Head & Neck Oncology 2010, 2 :22 (1 September 2010)
Abstract | Full text | PDF | PubMed
20.
Burden of paediatric Rotavirus Gastroenteritis (RVGE) and potential benefits of a universal Rotavirus vaccination programme with a pentavalent vaccine in Spain
Javier
Diez-Domingo,
Nuria
Suriñach,
Natalia
Alcalde,
Lourdes
Betegón,
Nathalie
Largeron,
Mélanie
Trichard
BMC Public Health 2010, 10 :469 (10 August 2010)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
21.
Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: A retrospective, population-based study
Leonardo
Gialloreti,
Monica
Merito,
Patrizio
Pezzotti,
Luigi
Naldi,
Antonio
Gatti,
Maud
Beillat,
Laurence
Serradell,
Rafaelle
di Marzo,
Antonio
Volpi
BMC Infectious Diseases 2010, 10 :230 (3 August 2010)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
22.
The impact of herpes zoster and post-herpetic neuralgia on quality-of-life
Robert
W
Johnson,
Didier
Bouhassira,
George
Kassianos,
Alain
Leplège,
Kenneth
E
Schmader,
Thomas
Weinke
BMC Medicine 2010, 8 :37 (21 June 2010)
Abstract | Full text | PDF | PubMed
|
Editor’s summary
The detrimental effects arising from herpes zoster and complications such as post-herpetic neuralgia on patients' quality of life are discussed, together with the potential and problems of antiviral therapies and vaccination.
23.
Evaluation of non-inferiority of intradermal versus adjuvanted seasonal influenza vaccine using two serological techniques: a randomised comparative study
Pierre
Van Damme,
Robert
Arnou,
Froukje
Kafeja,
Anne
Fiquet,
Patrick
Richard,
Stéphane
Thomas,
Gilles
Meghlaoui,
Sandrine
Samson,
Emilio
Ledesma
BMC Infectious Diseases 2010, 10 :134 (26 May 2010)
Abstract | Full text | PDF | PubMed |
24.
Epidemiology of Herpes Zoster Infection among Patients Treated in Primary Care Centres in the Valencian Community (Spain)
Ana
M
Cebrián-Cuenca,
Javier
Díez-Domingo,
María
Rodríguez,
Joan
Puig-Barberá,
Jorge
Navarro-Pérez,
BMC Family Practice 2010, 11 :33 (6 May 2010)
Abstract | Full text | PDF | PubMed
25.
A health economic model for evaluating a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in the UK
Lee
Moore,
Vanessa
Remy,
Monique
Martin,
Maud
Beillat,
Alistair
McGuire
Cost Effectiveness and Resource Allocation 2010, 8 :7 (30 April 2010)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central